MarketWatch reports that Synexus, which is a leader in the recruitment and running of clinical trials, is planning to double its clinical trial capacity in South Africa through the expansion of its Pretoria facilities, and by opening two new sites in Mamelodi and Soshanguwe.
Michael Fort, the CEO of Synexus, mentions:
"South Africa has proven to be one of our most successful sites both in terms of achieving high numbers of patients and also in the quality of the trials carried out. We will continue to expand our presence in South Africa."
The site in South Africa is well equipped with state of the art x-ray and DXA scanners for bone scanning. Staff members are estimated to grow to about 25 instead of the current 10.
Thursday, October 23, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment